ARCHIVES

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: Thomas Jordan Promoted At Bristol-Myers, Markison To Succeed Him In Oncology Div.

February 28, 1992

Tumor Size Predicts Survival In Early-Stage Lung Cancer

November 28, 2003

ONS Votes to Push Congress on DRGs

June 1, 1984

New Edition Of Book On Cancer Rates, Risks, Available

February 28, 1997

Cancer Genome Atlas Researchers Link Cell Metabolism Pathways To Disease Aggressiveness

July 26, 2013

Hatch Committee Clears Bill Blocking OMB Micromanagement

August 15, 1986